INSULIN-SECRETION, GASTRIC-INHIBITORY POLYPEPTIDE (GIP) AND GLUCAGON-LIKE PEPTIDE-1 (GLP-1) AFTER ORAL GLUCOSE IN CIRRHOSIS

被引：0
|
作者：
KRUSZYNSKA, Y
GHATEI, M
BLOOM, S
MCINTYRE, N
机构：
来源：
DIABETES | 1993年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A174 / A174
页数：1
相关论文
共 50 条
  • [21] Effects of diet on Glucagon-Like Peptide-1 (GLP-1), Glucose and Insulin response of young horses
    Duarte, SRR
    Carlson, O
    Egan, J
    Ralston, S
    PFERDEHEILKUNDE, 2005, 21 : 117 - 119
  • [22] The human glucagon-like peptide-1 (GLP-1) receptor
    Dillon, JS
    Wheeler, MB
    Leng, XH
    Ligon, BB
    Boyd, AE
    PHYSIOLOGY AND PATHOPHYSIOLOGY OF THE ISLETS OF LANGERHANS, 1997, 426 : 113 - 119
  • [23] THE COLON AS A SOURCE FOR GLUCAGON-LIKE PEPTIDE-1 (GLP-1)
    HOLST, JJ
    OLESEN, KM
    GUDMANDHOYER, E
    DEACON, CF
    HANSEN, CP
    JOHNSEN, AH
    MIHOLIC, J
    NAUCK, M
    QUALMANN, C
    DIABETOLOGIA, 1995, 38 : A170 - A170
  • [24] Somatostatin is a major, paracrine regulator of glucagon-like peptide-1 (GLP-1) secretion
    Hansen, L
    Mineo, H
    Bisgaard, T
    Jorgensen, PN
    Holst, JJ
    DIABETOLOGIA, 1997, 40 : 498 - 498
  • [25] Normal secretion and action of the gut incretin hormones glucagon like peptide-1 (GLP-1) and gastric inhibitory polypeptide (GIP) in young insulin resistant men with low birth weight (LBW)
    Schou, JH
    Pilgaard, K
    Holst, JJ
    Jensen, CB
    Vilsboll, T
    Madsbad, S
    Vaag, AA
    DIABETOLOGIA, 2003, 46 : A193 - A193
  • [26] Effects of gastric inhibitory polypeptide, glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists on Bone Cell Metabolism
    Hansen, Morten S. S.
    Tencerova, Michaela
    Frolich, Jacob
    Kassem, Moustapha
    Frost, Morten
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 122 (01) : 25 - 37
  • [27] MECHANISMS OF GLUCAGON-LIKE PEPTIDE-1(7-37) AND GASTRIC-INHIBITORY POLYPEPTIDE STIMULATION OF INSULIN GENE-EXPRESSION
    LU, M
    WHEELER, MB
    BOYD, AE
    DIABETES, 1994, 43 : A183 - A183
  • [28] Glucagon-like peptide-1 (GLP-1) is a powerful inhibitor of gastric emptying in man
    Näslund, E
    Skogar, S
    Grybäck, P
    Jacobsson, H
    Holst, JJ
    Hellström, PM
    GASTROENTEROLOGY, 1998, 114 (04) : A810 - A810
  • [29] Enhanced glucagon-like peptide-1 (GLP-1) secretion leads to rapid improvement of glucose tolerance and insulin secretion after laparoscopic sleeve gastrectomy (LSG)
    Kusunoki, Chisato
    Ugi, Satoshi
    Yamamoto, Hiroshi
    Kamo, Azusa
    Hashimoto, Tetsuya
    Nishio, Yoshihiko
    Kasama, Kazunori
    Tani, Toru
    Kashiwagi, Atsunori
    Maegawa, Hiroshi
    ENDOCRINE JOURNAL, 2010, 57 : S433 - S433
  • [30] INSULIN-SECRETION AND PLASMA-LEVELS OF GLUCOSE-DEPENDENT INSULINOTROPIC PEPTIDE AND GLUCAGON-LIKE PEPTIDE-1 [7-36 AMIDE] AFTER ORAL GLUCOSE IN CIRRHOSIS
    KRUSZYNSKA, YT
    GHATEI, MA
    BLOOM, SR
    MCINTYRE, N
    HEPATOLOGY, 1995, 21 (04) : 933 - 941
12345